SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-009919
Filing Date
2017-02-16
Accepted
2017-02-16 17:01:27
Documents
7
Period of Report
2017-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-4579_18k.htm 8-K 48823
2 EX-3.3 a17-4579_1ex3d3.htm EX-3.3 15518
3 EX-4.1 a17-4579_1ex4d1.htm EX-4.1 252746
4 EX-10.1 a17-4579_1ex10d1.htm EX-10.1 115253
5 EX-99.1 a17-4579_1ex99d1.htm EX-99.1 38350
6 GRAPHIC g45791mmi001.jpg GRAPHIC 11344
7 GRAPHIC g45791mmi002.jpg GRAPHIC 10850
  Complete submission text file 0001104659-17-009919.txt   502820
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

IRS No.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-12104 | Film No.: 17618628
SIC: 2835 In Vitro & In Vivo Diagnostic Substances